Photodynamic Therapy Market (Product Type: Photosensitizer Drugs and Devices; and Application: Cancer, Actinic Keratosis, Psoriasis, Acne, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Photodynamic Therapy Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Photodynamic Therapy Market Analysis and Forecast, 2017-2031
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Key Mergers & Acquisitions
• 5.2. Technological Advancements
• 5.3. Covid-19 Impact Analysis

6. Global Photodynamic Therapy Market Analysis and Forecast, by Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast, by Product Type, 2017-2031
  • 6.3.1. Photosensitizer Drugs
    • 6.3.1.1. Porphyrin Derivative (PD)
      • 6.3.1.1.1. Hematoporphyrin Derivative (HpD)
      • 6.3.1.1.2. Benzoporphyrin Derivative (BPD)
      • 6.3.1.1.3. Texaphyrins
      • 6.3.1.1.4. Others
    • 6.3.1.2. Aminolevulinic acid (ALA)
    • 6.3.1.3. Chlorines
    • 6.3.1.4. Others
  • 6.3.2. Devices
    • 6.3.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
    • 6.3.2.2. Diode Laser
• 6.4. Market Attractiveness Analysis, by Product Type

7. Global Photodynamic Therapy Market Analysis and Forecast, by Application

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast, by Application, 2017-2031
  • 7.3.1. Cancer
    • 7.3.1.1. Basal Cell Carcinoma
    • 7.3.1.2. Non-Small Cell Lung Cancer
    • 7.3.1.3. Head & Neck Cancer
    • 7.3.1.4. Others
  • 7.3.2. Actinic Keratosis (AK)
  • 7.3.3. Psoriasis
  • 7.3.4. Acne
  • 7.3.5. Others
• 7.4. Market Attractiveness Analysis, by Application

8. Global Photodynamic Therapy Market Analysis and Forecast, by End-user

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast, by End-user, 2017-2031
  • 8.3.1. Hospitals
  • 8.3.2. C&DC
  • 8.3.3. CCC
  • 8.3.4. Others
• 8.4. Market Attractiveness Analysis, by End-user

9. Global Photodynamic Therapy Market Analysis and Forecast, by Region

• 9.1. Key Findings
• 9.2. Market Value Forecast, by Region
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness Analysis, by Region

10. North America Photodynamic Therapy Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Product Type, 2017-2031
  • 10.2.1. Photosensitizer Drugs
    • 10.2.1.1. Porphyrin Derivative (PD)
      • 10.2.1.1.1. Hematoporphyrin Derivative (HpD)
      • 10.2.1.1.2. Benzoporphyrin Derivative (BPD)
      • 10.2.1.1.3. Texaphyrins
      • 10.2.1.1.4. Others
    • 10.2.1.2. Aminolevulinic acid (ALA)
    • 10.2.1.3. Chlorines
    • 10.2.1.4. Others
  • 10.2.2. Devices
    • 10.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
    • 10.2.2.2. Diode Laser
• 10.3. Market Value Forecast, by Application, 2017-2031
  • 10.3.1. Cancer
    • 10.3.1.1. Basal Cell Carcinoma
    • 10.3.1.2. Non-Small Cell Lung Cancer
    • 10.3.1.3. Head & Neck Cancer
    • 10.3.1.4. Others
  • 10.3.2. Actinic Keratosis (AK)
  • 10.3.3. Psoriasis
  • 10.3.4. Acne
  • 10.3.5. Others
• 10.4. Market Value Forecast, by End-user, 2017-2031
  • 10.4.1. Hospitals
  • 10.4.2. C&DC
  • 10.4.3. CCC
  • 10.4.4. Others
• 10.5. Market Value Forecast, by Country, 2017-2031
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Product Type
  • 10.6.2. By Application
  • 10.6.3. By End-user
  • 10.6.4. By Country

11. Europe Photodynamic Therapy Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product Type, 2017-2031
  • 11.2.1. Photosensitizer Drugs
    • 11.2.1.1. Porphyrin Derivative (PD)
      • 11.2.1.1.1. Hematoporphyrin Derivative (HpD)
      • 11.2.1.1.2. Benzoporphyrin Derivative (BPD)
      • 11.2.1.1.3. Texaphyrins
      • 11.2.1.1.4. Others
    • 11.2.1.2. Aminolevulinic acid (ALA)
    • 11.2.1.3. Chlorines
    • 11.2.1.4. Others
  • 11.2.2. Devices
    • 11.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
    • 11.2.2.2. Diode Laser
• 11.3. Market Value Forecast, by Application, 2017-2031
  • 11.3.1. Cancer
    • 11.3.1.1. Basal Cell Carcinoma
    • 11.3.1.2. Non-Small Cell Lung Cancer
    • 11.3.1.3. Head & Neck Cancer
    • 11.3.1.4. Others
  • 11.3.2. Actinic Keratosis (AK)
  • 11.3.3. Psoriasis
  • 11.3.4. Acne
  • 11.3.5. Others
• 11.4. Market Value Forecast, by End-user, 2017-2031
  • 11.4.1. Hospitals
  • 11.4.2. C&DC
  • 11.4.3. CCC
  • 11.4.4. Others
• 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 11.5.1. Germany
  • 11.5.2. U.K.
  • 11.5.3. France
  • 11.5.4. Italy
  • 11.5.5. Spain
  • 11.5.6. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Product Type
  • 11.6.2. By Application
  • 11.6.3. By End-user
  • 11.6.4. By Country/Sub-region

12. Asia Pacific Photodynamic Therapy Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product Type, 2017-2031
  • 12.2.1. Photosensitizer Drugs
    • 12.2.1.1. Porphyrin Derivative (PD)
      • 12.2.1.1.1. Hematoporphyrin Derivative (HpD)
      • 12.2.1.1.2. Benzoporphyrin Derivative (BPD)
      • 12.2.1.1.3. Texaphyrins
      • 12.2.1.1.4. Others
    • 12.2.1.2. Aminolevulinic acid (ALA)
    • 12.2.1.3. Chlorines
    • 12.2.1.4. Others
  • 12.2.2. Devices
    • 12.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
    • 12.2.2.2. Diode Laser
• 12.3. Market Value Forecast, by Application, 2017-2031
  • 12.3.1. Cancer
    • 12.3.1.1. Basal Cell Carcinoma
    • 12.3.1.2. Non-Small Cell Lung Cancer
    • 12.3.1.3. Head & Neck Cancer
    • 12.3.1.4. Others
  • 12.3.2. Actinic Keratosis (AK)
  • 12.3.3. Psoriasis
  • 12.3.4. Acne
  • 12.3.5. Others
• 12.4. Market Value Forecast, by End-user, 2017-2031
  • 12.4.1. Hospitals
  • 12.4.2. C&DC
  • 12.4.3. CCC
  • 12.4.4. Others
• 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 12.5.1. China
  • 12.5.2. India
  • 12.5.3. Japan
  • 12.5.4. Australia & New Zealand
  • 12.5.5. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Product Type
  • 12.6.2. By Application
  • 12.6.3. By End-user
  • 12.6.4. By Country/Sub-region

13. Latin America Photodynamic Therapy Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product Type, 2017-2031
  • 13.2.1. Photosensitizer Drugs
    • 13.2.1.1. Porphyrin Derivative (PD)
      • 13.2.1.1.1. Hematoporphyrin Derivative (HpD)
      • 13.2.1.1.2. Benzoporphyrin Derivative (BPD)
      • 13.2.1.1.3. Texaphyrins
      • 13.2.1.1.4. Others
    • 13.2.1.2. Aminolevulinic acid (ALA)
    • 13.2.1.3. Chlorines
    • 13.2.1.4. Others
  • 13.2.2. Devices
    • 13.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
    • 13.2.2.2. Diode Laser
• 13.3. Market Value Forecast, by Application, 2017-2031
  • 13.3.1. Cancer
    • 13.3.1.1. Basal Cell Carcinoma
    • 13.3.1.2. Non-Small Cell Lung Cancer
    • 13.3.1.3. Head & Neck Cancer
    • 13.3.1.4. Others
  • 13.3.2. Actinic Keratosis (AK)
  • 13.3.3. Psoriasis
  • 13.3.4. Acne
  • 13.3.5. Others
• 13.4. Market Value Forecast, by End-user, 2017-2031
  • 13.4.1. Hospitals
  • 13.4.2. C&DC
  • 13.4.3. CCC
  • 13.4.4. Others
• 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Product Type
  • 13.6.2. By Application
  • 13.6.3. By End-user
  • 13.6.4. By Country/Sub-region

14. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Product Type, 2017-2031
  • 14.2.1. Photosensitizer Drugs
    • 14.2.1.1. Porphyrin Derivative (PD)
      • 14.2.1.1.1. Hematoporphyrin Derivative (HpD)
      • 14.2.1.1.2. Benzoporphyrin Derivative (BPD)
      • 14.2.1.1.3. Texaphyrins
      • 14.2.1.1.4. Others
    • 14.2.1.2. Aminolevulinic acid (ALA)
    • 14.2.1.3. Chlorines
    • 14.2.1.4. Others
  • 14.2.2. Devices
    • 14.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
    • 14.2.2.2. Diode Laser
• 14.3. Market Value Forecast, by Application, 2017-2031
  • 14.3.1. Cancer
    • 14.3.1.1. Basal Cell Carcinoma
    • 14.3.1.2. Non-Small Cell Lung Cancer
    • 14.3.1.3. Head & Neck Cancer
    • 14.3.1.4. Others
  • 14.3.2. Actinic Keratosis (AK)
  • 14.3.3. Psoriasis
  • 14.3.4. Acne
  • 14.3.5. Others
• 14.4. Market Value Forecast, by End-user, 2017-2031
  • 14.4.1. Hospitals
  • 14.4.2. C&DC
  • 14.4.3. CCC
  • 14.4.4. Others
• 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Product Type
  • 14.6.2. By Application
  • 14.6.3. By End-user
  • 14.6.4. By Country/Sub-region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (by tier and size of companies)
• 15.2. Market Share Analysis, by Company, 2021
• 15.3. Company Profiles
  • 15.3.1. Galderma Laboratories, L.P.
    • 15.3.1.1. Company Overview
    • 15.3.1.2. Financial Overview
    • 15.3.1.3. Product Portfolio
    • 15.3.1.4. Business Strategies
    • 15.3.1.5. Recent Developments
  • 15.3.2. Biofrontera AG
    • 15.3.2.1. Company Overview
    • 15.3.2.2. Financial Overview
    • 15.3.2.3. Product Portfolio
    • 15.3.2.4. Business Strategies
    • 15.3.2.5. 15.3.1.5. Recent Developments
  • 15.3.3. Excel Lasers Limited
    • 15.3.3.1. Company Overview
    • 15.3.3.2. Financial Overview
    • 15.3.3.3. Product Portfolio
    • 15.3.3.4. Business Strategies
    • 15.3.3.5. Recent Developments
  • 15.3.4. LUMIBIRD group (Quantel Medical)
    • 15.3.4.1. Company Overview
    • 15.3.4.2. Financial Overview
    • 15.3.4.3. Product Portfolio
    • 15.3.4.4. Business Strategies
    • 15.3.4.5. Recent Developments
  • 15.3.5. Modulight Corporation
    • 15.3.5.1. Company Overview
    • 15.3.5.2. Financial Overview
    • 15.3.5.3. Product Portfolio
    • 15.3.5.4. Business Strategies
    • 15.3.5.5. Recent Developments
  • 15.3.6. Quest PharmaTech, Inc.
    • 15.3.6.1. Company Overview
    • 15.3.6.2. Financial Overview
    • 15.3.6.3. Product Portfolio
    • 15.3.6.4. Business Strategies
    • 15.3.6.5. Recent Developments
  • 15.3.7. Theralase Technologies, Inc.
    • 15.3.7.1. Company Overview
    • 15.3.7.2. Financial Overview
    • 15.3.7.3. Product Portfolio
    • 15.3.7.4. Business Strategies
    • 15.3.7.5. Recent Developments
  • 15.3.8. SUS Advancing Technology Co., Ltd.
    • 15.3.8.1. Company Overview
    • 15.3.8.2. Financial Overview
    • 15.3.8.3. Product Portfolio
    • 15.3.8.4. Business Strategies
    • 15.3.8.5. Recent Developments

List of Tables

• Table 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
• Table 02: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
• Table 03: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
• Table 04: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
• Table 05: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
• Table 06: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
• Table 07: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
• Table 08: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region , 2017-2031
• Table 09: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country, 2017-2031
• Table 10: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type,2017-2031
• Table 11: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
• Table 12: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
• Table 13: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices,2017-2031
• Table 14: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
• Table 15: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
• Table 16: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
• Table 17: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
• Table 18: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
• Table 19: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drug, 2017-2031
• Table 20: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
• Table 21: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
• Table 22: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
• Table 23: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
• Table 24: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
• Table 25: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
• Table 26: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
• Table 27: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
• Table 28: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
• Table 29: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
• Table 30: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
• Table 31: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
• Table 32: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
• Table 33: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
• Table 34: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
• Table 35: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
• Table 36: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
• Table 37: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
• Table 38: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
• Table 39: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
• Table 40: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
• Table 41: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
• Table 42: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
• Table 43: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
• Table 44: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
• Table 45: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
• Table 46: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
• Table 47: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
• Table 48: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

• Figure 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, 2017-2031
• Figure 02: Global Photodynamic Therapy Market Value Share (%), by Product Type, 2021
• Figure 03: Global Photodynamic Therapy Market Value Share (%), by Drugs, 2021
• Figure 04: Global Photodynamic Therapy Market Value Share (%), by Application, 2021
• Figure 05: Global Photodynamic Therapy Market Value Share (%), by Region, 2021
• Figure 06: Global Photodynamic Therapy Market Value Share (%), by Product Type, 2017 and 2031
• Figure 07: Global Photodynamic Therapy Market Value Share (%), by Photosensitizer Drugs, 2017 and 2031
• Figure 08: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Photosensitizer Drugs, 2017-2031
• Figure 09: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Devices, 2017-2031
• Figure 10: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Porphyrin Derivative (PD), 2017-2031
• Figure 11: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aminolevulinic Acid (ALA), 2017-2031
• Figure 12: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chlorines, 2017-2031
• Figure 13: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
• Figure 14: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DFOLDD, 2017-2031
• Figure 15: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diode Laser, 2017-2031
• Figure 16: Global Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2021-2031
• Figure 17: Global Photodynamic Therapy Market Attractiveness Analysis, by Photosensitizer Drugs, 2021-2031
• Figure 18: Global Photodynamic Therapy Market Attractiveness Analysis, by Devices, 2021-2031
• Figure 19: Global Photodynamic Therapy Market Value Share (%), by Application, 2017 and 2031
• Figure 20: Global Photodynamic Therapy Market Attractiveness Analysis, by Application, 2021-2031
• Figure 21: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer, 2017-2031
• Figure 22: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Actinic Keratosis (AK), 2017-2031
• Figure 23: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Psoriasis, 2017-2031
• Figure 24: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Acne, 2017-2031
• Figure 25: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
• Figure 26: Global Photodynamic Therapy Market Value Share (%), by End-user, 2017 and 2031
• Figure 27: Global Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 28: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2031
• Figure 29: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmetics & Dermatology Clinics, 2017-2031
• Figure 30: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer Treatment Centers, 2017-2031
• Figure 31: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
• Figure 32: Global Photodynamic Therapy Market Value Share Analysis, by Region, 2017 and 2031
• Figure 33: Global Photodynamic Therapy Market Attractiveness Analysis, by Region, 2021-2031
• Figure 34: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 35: North America Photodynamic Therapy Market Value Share (%), by Country, 2017 and 2031
• Figure 36: North America Photodynamic Therapy Market Attractiveness Analysis, by Country, 2022-2031
• Figure 37: North America Photodynamic Therapy Market Value Share, by Product Type, 2017and 2031
• Figure 38: North America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022-2031
• Figure 39: North America Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
• Figure 40: North America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022-2031
• Figure 41: North America Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
• Figure 42: North America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 43: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 44: Europe Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017and 2031
• Figure 45: Europe Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 46: Europe Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
• Figure 47: Europe Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022-2031
• Figure 48: Europe Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
• Figure 49: Europe Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022-2031
• Figure 50: Europe Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
• Figure 51: Europe Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 52: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 53: Asia Pacific Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031
• Figure 54: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 55: Asia Pacific Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
• Figure 56: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022-2031
• Figure 57: Asia Pacific Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
• Figure 58: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022-2031
• Figure 59: Asia Pacific Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
• Figure 60: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 61: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 62: Latin America Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031
• Figure 63: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 64: Latin America Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
• Figure 65: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2017-2031
• Figure 66: Latin America Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
• Figure 67: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2017-2031
• Figure 68: Latin America Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
• Figure 69: Latin America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 70: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 71: Middle East & Africa Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031
• Figure 72: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 73: Middle East & Africa Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
• Figure 74: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022-2031
• Figure 75: Middle East & Africa Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
• Figure 76: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022-2031
• Figure 77: Middle East & Africa Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
• Figure 78: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031